Foreign pharma firms demand halt to Polish reimbursement law favouring domestic manufacturers

Poland's Ministry of Health is finalising an amendment to the reimbursement law that would favour domestic drug manufacturers or companies relocating production to Poland. Foreign pharmaceutical giants have demanded a halt to the legislative process, opposing the provisions known as SZNUR. The dispute between Polish domestic producers and Big Pharma involves substantial financial stakes and the future shape of the Polish pharmaceutical market.

Similar stories

🏥 Health Insulin pumps on public funding for adults over 26 in Poland — patients worry about eligibility criteria TVN24 · 2d ago 🏥 Health Medical Council: Health Ministry proposals after hospital scandal will harm patients TVN24 · 3d ago 🏥 Health Doctors warn government health reform could close clinics and worsen shortages Rzeczpospolita · 3d ago